Kumquat Biosciences

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Kumquat Biosciences sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).

6 total trials 6 currently recruiting early-phase tilt upper quartile by trial count

Kumquat Biosciences: 6 sponsored US clinical trials, 6 recruiting.

Kumquat Biosciences sponsors 6 registered US clinical trials on ClinicalTrials.gov, 6 of them currently recruiting. 0 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Solid Tumor Malignancies, with 3 trials.

Upper-quartile sponsor footprint

Kumquat Biosciences sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

6 total, page 1 of 1

RECRUITING Phase 2

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)

NCT07406633
RECRUITING Phase 1

A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies

NCT07207707
RECRUITING Phase 1

A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

NCT06994806
RECRUITING Phase 1

A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

NCT06720987
RECRUITING Phase 1

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Hematologic Malignancies

NCT06645886
RECRUITING Phase 1

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

NCT06507306

Phase Distribution

PhaseTrial count
Phase 1 5
Phase 2 1

Therapeutic Areas

Solid Tumor Malignancies 3
KRAS G12S Mutation 1
KRAS G12C Mutation 1
CRC, Colorectal Cancer 1
Adult 1
Hematologic Malignancies 1
Solid Tumor, Adult 1

What is open in the Kumquat Biosciences pipeline

6 recruiting of 6 indexed (100% open).

Phase mix: 0 late (III/IV) vs 6 early (I/II) (early-phase heavy).

Top condition: Solid Tumor Malignancies (3 trials), 6 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Kumquat Biosciences: open-pipeline peers nationwide

Peers matched on 6 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

Kumquat Biosciences sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1234567 0%50%100%150% Total trials Recruiting share Kumquat Biosciences23andMeAardvark TherapeuticsAbbisko Therapeutics CoAbGenomics B.V Taiwan BranchAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
Kumquat Biosciences sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Kumquat Biosciences sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 6 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Kumquat Biosciences page

6 registered trials is a research-attention snapshot, not an endorsement of Kumquat Biosciences or any single study.

  • 6 of Kumquat Biosciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Solid Tumor Malignancies is the condition Kumquat Biosciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Solid Tumor Malignancies trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Kumquat Biosciences pipeline card: 6 registered trials from official public datasets.Report a data error.